1-((Benzyloxy)Carbonyl)-5-(Trifluoromethyl)Piperidine-3-Carboxylic Acid(WX611727)
![]() |
- $384 - $1008.8
- Product name: 1-((Benzyloxy)Carbonyl)-5-(Trifluoromethyl)Piperidine-3-Carboxylic Acid(WX611727)
- CAS: 1822817-65-1
- MF: C15H16F3NO4
- MW: 331.29
- EINECS:
- MDL Number:MFCD28119166
- Synonyms:1-((Benzyloxy)Carbonyl)-5-(Trifluoromethyl)Piperidine-3-Carboxylic Acid(WX611727);1-((BENZYLOXY)CARBONYL)-5-(TRIFLUOROMETHYL)PIPERIDINE-3-CARBOXYLIC ACID;1,3-Piperidinedicarboxylic acid, 5-(trifluoromethyl)-, 1-(phenylmethyl) ester
3 prices
Selected condition:
Brand
- Alichem
- Crysdot
Package
- 250mg
- 1g
- ManufacturerAlichem
- Product number1822817651
- Product description1-((Benzyloxy)carbonyl)-5-(trifluoromethyl)piperidine-3-carboxylicacid
- Packaging1g
- Price$1008.8
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11180839
- Product description1-((Benzyloxy)carbonyl)-5-(trifluoromethyl)piperidine-3-carboxylicacid 95+%
- Packaging250mg
- Price$384
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11180839
- Product description1-((Benzyloxy)carbonyl)-5-(trifluoromethyl)piperidine-3-carboxylicacid 95+%
- Packaging1g
- Price$962
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1822817651 | 1-((Benzyloxy)carbonyl)-5-(trifluoromethyl)piperidine-3-carboxylicacid | 1g | $1008.8 | 2021-12-16 | Buy |
Crysdot | CD11180839 | 1-((Benzyloxy)carbonyl)-5-(trifluoromethyl)piperidine-3-carboxylicacid 95+% | 250mg | $384 | 2021-12-16 | Buy |
Crysdot | CD11180839 | 1-((Benzyloxy)carbonyl)-5-(trifluoromethyl)piperidine-3-carboxylicacid 95+% | 1g | $962 | 2021-12-16 | Buy |
Properties
Boiling point :436.5±45.0 °C(Predicted)
Density :1.373±0.06 g/cm3(Predicted)
pka :4.18±0.40(Predicted)
Density :1.373±0.06 g/cm3(Predicted)
pka :4.18±0.40(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|